The transposon-facilitated recombination system of Johnson and Romig (4) was used in conjunction with an RJ1 donor strain and a 3083-2 recipient strain to map the position of tox-1000. The procedural details of the mating experiments have been previously described (6) . Strain MB2020(pSJ13) (RJ1: :Tnl-24, vct-i, tox-1000, and rif-5001) was used as the donor strain. The plasmid pSJ13 has a Tni insertion in the (-) orientation (4) . The recipient strain MB1823 (vct-2, tox-2000, str-5000, met-5000, trp-5000, and his-5002) was derived from the previously described strain MB1813 by mutagenesis with N-methyl-N'-nitro-N-nitrosoguanidine (6) . Recombinants were tested for expression of tox-1000 or tox-2000 with a variation (3) of the radial passive immune hemolysis assay for CT (2) . Strain RJ1 and recombinants with the tox-1000 allele were negative in this assay, whereas strain 3083-2 and recombinants with the tox-2000 allele were positive.
The data in Table 1 indicate that when Met' was the selected phenotype, cotransfer of trp or his with met did not occur at a significant frequency. When either Trp+ or His' was the selected phenotype, cotransfer of met with trp or his occurred infrequently or not at all. Therefore, recombination analysis could not be used to order met, trp, and his relative to each other. However, the frequency of marker transfer data in Table 1 suggests that the order of the loci relative to the origin of transfer was met-trp-his, which was consistent with the map order determined by other authors for phenotypically similar markers (5, 7 in Table 2 are consistent with the His+ Trp+ Tox+ recombinant class resulting from a double crossover and from the order of the three genes being his-tox-1000-trp.
The mechanism by which the net level of CT production is affected by tox-1000 and tox-2000 is not known. However, the tox-1000 allele is apparently an important determinant of the amount of CT produced by RJ1, since introduction of tox-1000 into strain 3083-2 reduces the normally high level of CT produced by this strain to levels that are no longer detectable in the relatively sensitive radial passive immune hemolysis assay. Our data suggest that a possible location of CT structural gene information (i.e., the vct locus) is separated from a potentially important regulatory locus (i.e., tox) by at least one gene that is not related to CT synthesis (i.e., trp). This suggestion implies that tox may code for a diffusable product that regulates CT synthesis. The phenotype associated with tox-1000 is similar to the Tox-mutants of the tox-i locus of strain 569B (1) and the low-level allele of tox-i located in classical strain 162 (8). It is not known whether tox-1000 and tox-I affect the same aspect of CT production. However, if tox-1000 and tox-i are alleles, then the gene order of the his region of the El Tor biotype genetic map is inverted relative to the classical biotype genetic map since Baine et al. positioned his-i between tox-i and trp-i (1). A similar inversion of the El Tor genetic map relative to the classical map has been reported for the ilv-lys region of the chromosome (4 
